IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Third Rock Ventures, LLC

Q4 2014 Holdings

Filed 2015-01-26 | 6 holdings | $344.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Agios Pharmaceuticals, Inc.(AGIO)COM00847X104$344.0M3,070,09099.7%
Sage Therapeutics, Inc.(SG7)COM78667J108$427.5K11,681,0080.1%
Zafgen Inc.COM98885E103$172.8K5,602,0450.1%
bluebird bio, Inc.COM09609G100$111.4K1,215,0540.0%
Foundation Medicine, Inc.COM350465100$109.5K4,927,2340.0%
Eleven Biotherapeutics, Inc.COM286221106$57.5K4,841,5910.0%